We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Test for Staph Infections

By Labmedica staff writers
Posted on 30 Nov 2005
A new test has been launched that detects both methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible Staphylococcus aureus (MSSA).

The Staphaurex Plus is a rapid and convenient latex agglutination test that is able to detect MRSA as well as MSSA. The latex particles in Staphaurex Plus are coated with fibrinogen and specific polyclonal antibodies directed towards difficult Staph aureus strains, including MRSA. In the presence of target organisms, the latex particles agglutinate to provide a strong and easily visible positive reaction. In the absence of target organism, the particles remain in smooth suspension. The sensitivity of the test is
> 98% for all S aureus strains.

Everything required to perform the test is provided in the kit, including reaction cards, mixing sticks, and a control latex to eliminate nonspecific agglutination. Kits are available for 150 or 450 tests. The test was developed by Oxoid (Basingstoke, UK).

Oxoid has additional products available for the detection of MRSA. These include a latex agglutination test for the detection of penicillin-binding protein 2 expressed by the MecA gene for resistance in MRSA strains. The Staphytect Plus and Dryspot Staphytcct Plus latex agglutination tests are for the detection of MSSA and MRSA. Oxoid also offers products for screening samples for MRSA and for the detection of MRSA in routine swab samples.




Related Links:
Oxoid

Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Immunofluorescence Analyzer
IFA System

Latest Industry News

Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases
30 Nov 2005  |   Industry

Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal
30 Nov 2005  |   Industry

Bruker Expands NGS Capabilities for Sepsis and Bloodstream Infections
30 Nov 2005  |   Industry



PURITAN MEDICAL